Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Genotyping P450 2C19 on Hospitalization Period When Voriconazole Treatment is Started

NCT03554239 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03554239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03554239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Genotyping P450 2C19 on Hospitalization Period When Voriconazole Treatment is Started
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2016
Completion date
December 31, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infection